LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 16 filers reported holding LAVA THERAPEUTICS NV in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,090,814 | -26.6% | 2,074,372 | 0.0% | 0.15% | -9.3% |
Q2 2023 | $4,210,975 | +22.3% | 2,074,372 | 0.0% | 0.16% | +8.7% |
Q1 2023 | $3,443,458 | -65.1% | 2,074,372 | -26.3% | 0.15% | -63.0% |
Q4 2022 | $9,856,686 | -23.4% | 2,816,196 | 0.0% | 0.40% | -19.2% |
Q3 2022 | $12,870,000 | +59.8% | 2,816,196 | 0.0% | 0.50% | +62.0% |
Q2 2022 | $8,054,000 | -35.0% | 2,816,196 | 0.0% | 0.31% | -20.4% |
Q1 2022 | $12,391,000 | -20.0% | 2,816,196 | 0.0% | 0.39% | +9.9% |
Q4 2021 | $15,489,000 | -7.1% | 2,816,196 | 0.0% | 0.35% | +21.0% |
Q3 2021 | $16,672,000 | -45.6% | 2,816,196 | 0.0% | 0.29% | -35.8% |
Q2 2021 | $30,640,000 | -28.6% | 2,816,196 | -0.3% | 0.45% | -25.0% |
Q1 2021 | $42,903,000 | – | 2,824,409 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 771,874 | $1,150,092 | 0.39% |
Novo Holdings A/S | 2,400,000 | $3,528,000 | 0.26% |
Redmile Group, LLC | 2,074,372 | $3,090,814 | 0.15% |
Alpha Wave Global, LP | 109,097 | $162,555 | 0.10% |
Artal Group S.A. | 200,000 | $294 | 0.01% |
Tower Research Capital LLC (TRC) | 11,960 | $17,581 | 0.00% |
OSAIC HOLDINGS, INC. | 48 | $71 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 65,000 | $95,550 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 100 | $149 | 0.00% |